15 funds hold it.Insiders net buying.
Net buying: insiders sold $0 and bought $22K on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsLast report
Jul 23, 2026
Period ending
Jun 30, 2026
Earnings per share
-$0.12 expected
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Jun 30, 2026Reported Jul 23, 2026 | -$0.13est. -$0.12 | -8.33%miss | $272.8KSEC filing | -19.7%from $339.5K |
| Mar 31, 2026Reported May 7, 2026 | -$0.13est. -$0.15 | +13.33%beat | $313.5KAlpha Vantage | -60.1%from $785.8K |
| Dec 31, 2025Reported Mar 24, 2026 | -$0.26est. -$0.13 | -102.38%miss | $374.4KAlpha Vantage | -76.6%from $1.6M |
| Sep 30, 2025Reported Oct 30, 2025 | -$0.31est. -$0.02 | -$0.29miss | $54.1KAlpha Vantage | -90.3%from $556.4K |
| Jun 30, 2025Reported Aug 14, 2025 | -$0.29est. -$0.19 | -52.63%miss | $339.5KSEC filing | -21.9%from $434.8K |
| Mar 31, 2025Reported May 8, 2025 | -$0.31est. -$0.20 | -55.00%miss | $785.8KAlpha Vantage | +84.5%from $426.0K |
| Dec 31, 2024Reported Mar 6, 2025 | -$2.31est. -$0.03 | -$2.28miss | $1.6MAlpha Vantage | +257.2%from $447.7K |
| Sep 30, 2024Reported Oct 22, 2024 | -$0.08est. -$0.03 | -$0.05miss | $556.4KAlpha Vantage | -26.9%from $760.7K |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $54.1K | $374.4K | $313.5K | $272.8K |
| Cost of what it sold | $1.6M | $2.3M | $2.0M | $1.2M |
| Gross profit | -$1.6M | -$1.9M | -$1.7M | -$896.1K |
| What it spent | ||||
| Research and development | $2.2M | $4.7M | $2.1M | $2.3M |
| Sales and admin | $6.1M | $6.7M | $6.6M | $7.3M |
| Other operating costs | -$127.7K | — | — | $16.4M |
| Total operating expenses | $8.2M | $11.3M | $8.7M | $26.0M |
| What was left | ||||
| Operating profit | -$9.8M | -$13.2M | -$10.3M | -$26.9M |
| Interest on debt | $336.1K | $158.5K | $148.0K | $222.4K |
| Profit before tax | -$12.9M | -$13.4M | -$9.4M | -$25.5M |
| Net profit | -$12.9M | -$13.3M | -$9.4M | -$25.5M |
| EBITDA | -$11.3M | -$11.5M | -$7.9M | -$10.4M |
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace